001     257318
005     20231004134632.0
024 7 _ |a 10.1016/j.xgen.2023.100261
|2 doi
024 7 _ |a pmid:36950378
|2 pmid
024 7 _ |a pmc:PMC10025424
|2 pmc
024 7 _ |a altmetric:142213685
|2 altmetric
037 _ _ |a DZNE-2023-00387
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Bressan, Elisangela
|0 P:(DE-2719)2812124
|b 0
|e First author
|u dzne
245 _ _ |a The Foundational Data Initiative for Parkinson Disease: Enabling efficient translation from genetic maps to mechanism.
260 _ _ |a Amsterdam
|c 2023
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1683892529_24934
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a CC BY
520 _ _ |a The Foundational Data Initiative for Parkinson Disease (FOUNDIN-PD) is an international collaboration producing fundamental resources for Parkinson disease (PD). FOUNDIN-PD generated a multi-layered molecular dataset in a cohort of induced pluripotent stem cell (iPSC) lines differentiated to dopaminergic (DA) neurons, a major affected cell type in PD. The lines were derived from the Parkinson's Progression Markers Initiative study, which included participants with PD carrying monogenic PD variants, variants with intermediate effects, and variants identified by genome-wide association studies and unaffected individuals. We generated genetic, epigenetic, regulatory, transcriptomic, and longitudinal cellular imaging data from iPSC-derived DA neurons to understand molecular relationships between disease-associated genetic variation and proximate molecular events. These data reveal that iPSC-derived DA neurons provide a valuable cellular context and foundational atlas for modeling PD genetic risk. We have integrated these data into a FOUNDIN-PD data browser as a resource for understanding the molecular pathogenesis of PD.
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Parkinson disease
|2 Other
650 _ 7 |a dopaminergic neurons
|2 Other
650 _ 7 |a genetic risk
|2 Other
650 _ 7 |a induced pluripotent stem cell
|2 Other
650 _ 7 |a omics single-cell RNA sequencing single-cell ATAC sequencing SNCA LRRK2 GBA1
|2 Other
700 1 _ |a Reed, Xylena
|b 1
700 1 _ |a Bansal, Vikas
|0 P:(DE-2719)2812055
|b 2
|u dzne
700 1 _ |a Hutchins, Elizabeth
|b 3
700 1 _ |a Cobb, Melanie M
|b 4
700 1 _ |a Webb, Michelle G
|b 5
700 1 _ |a Alsop, Eric
|b 6
700 1 _ |a Grenn, Francis P
|b 7
700 1 _ |a Illarionova, Anastasia
|0 P:(DE-2719)2812762
|b 8
|u dzne
700 1 _ |a Savytska, Natalia
|0 P:(DE-2719)2812754
|b 9
|u dzne
700 1 _ |a Violich, Ivo
|b 10
700 1 _ |a Bröer, Stefanie
|0 P:(DE-2719)2812710
|b 11
|u dzne
700 1 _ |a Alves Fernandes, Noemia Rita
|0 P:(DE-2719)2811866
|b 12
|u dzne
700 1 _ |a Sivakumar, Ramiyapriya
|b 13
700 1 _ |a Beilina, Alexandra
|b 14
700 1 _ |a Billingsley, Kimberley J
|b 15
700 1 _ |a Berghausen, Joos
|b 16
700 1 _ |a Pantazis, Caroline B
|b 17
700 1 _ |a Pitz, Vanessa
|b 18
700 1 _ |a Patel, Dhairya
|b 19
700 1 _ |a Daida, Kensuke
|b 20
700 1 _ |a Meechoovet, Bessie
|b 21
700 1 _ |a Reiman, Rebecca
|b 22
700 1 _ |a Courtright-Lim, Amanda
|b 23
700 1 _ |a Logemann, Amber
|b 24
700 1 _ |a Antone, Jerry
|b 25
700 1 _ |a Barch, Mariya
|b 26
700 1 _ |a Kitchen, Robert
|b 27
700 1 _ |a Li, Yan
|b 28
700 1 _ |a Dalgard, Clifton L
|b 29
700 1 _ |a Center, American Genome
|b 30
|e Collaboration Author
700 1 _ |a Rizzu, Patrizia
|0 P:(DE-2719)2810718
|b 31
|u dzne
700 1 _ |a Hernandez, Dena Michelle Godwin
|0 P:(DE-2719)2812102
|b 32
|u dzne
700 1 _ |a Hjelm, Brooke E
|b 33
700 1 _ |a Nalls, Mike
|b 34
700 1 _ |a Gibbs, J Raphael
|b 35
700 1 _ |a Finkbeiner, Steven
|b 36
700 1 _ |a Cookson, Mark R
|b 37
700 1 _ |a Van Keuren-Jensen, Kendall
|b 38
700 1 _ |a Craig, David W
|b 39
700 1 _ |a Singleton, Andrew B
|b 40
700 1 _ |a Heutink, Peter
|0 P:(DE-2719)2810728
|b 41
|u dzne
700 1 _ |a Blauwendraat, Cornelis
|0 P:(DE-2719)2810837
|b 42
|u dzne
773 _ _ |a 10.1016/j.xgen.2023.100261
|g Vol. 3, no. 3, p. 100261 -
|0 PERI:(DE-600)3110160-4
|n 3
|p 100261
|t Cell genomics
|v 3
|y 2023
|x 2666-979X
856 4 _ |u https://pub.dzne.de/record/257318/files/DZNE-2023-00387.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/257318/files/DZNE-2023-00387.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:257318
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2812124
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2812055
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)2812762
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2812754
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 11
|6 P:(DE-2719)2812710
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 12
|6 P:(DE-2719)2811866
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 31
|6 P:(DE-2719)2810718
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 32
|6 P:(DE-2719)2812102
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 41
|6 P:(DE-2719)2810728
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 42
|6 P:(DE-2719)2810837
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 0
914 1 _ |y 2023
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-09T12:14:04Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-09T12:14:04Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Double anonymous peer review
|d 2023-05-09T12:14:04Z
920 1 _ |0 I:(DE-2719)1210002
|k AG Heutink 1
|l Genome Biology of Neurodegenerative Diseases
|x 0
920 1 _ |0 I:(DE-2719)1210009
|k AG Rizzu
|l Applied Genomics for Neurodegenerative Diseases
|x 1
920 1 _ |0 I:(DE-2719)1240005
|k Core ICRU
|l Core ICRU
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1210002
980 _ _ |a I:(DE-2719)1210009
980 _ _ |a I:(DE-2719)1240005
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21